11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus.
Glucocorticoids play an important role in the pathogenesis of obesity and insulin resistance. Impaired conversion of cortisone (E) to cortisol (F) by the type 1 isoenzyme of 11beta-hydroxysteroid dehydrogenase (11beta-HSD) in obesity may represent a protective mechanism preventing ongoing weight gai...
Κύριοι συγγραφείς: | Valsamakis, G, Anwar, A, Tomlinson, J, Shackleton, C, McTernan, P, Chetty, R, Wood, P, Banerjee, A, Holder, G, Barnett, A, Stewart, P, Kumar, S |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2004
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity.
ανά: Stewart, P, κ.ά.
Έκδοση: (2002) -
Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity.
ανά: Tomlinson, J, κ.ά.
Έκδοση: (2003) -
Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.
ανά: Tomlinson, J, κ.ά.
Έκδοση: (2004) -
Cerebrospinal fluid production - A role for 11 beta-hydroxysteroid dehydrogenase type 1?
ανά: Rauz, S, κ.ά.
Έκδοση: (2004) -
Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
ανά: Tomlinson, J, κ.ά.
Έκδοση: (2001)